ALLERGAN FDA Approval NDA 019219

NDA 019219

ALLERGAN

FDA Drug Application

Application #019219

Documents

Label2003-04-15
Letter2017-12-27
Label2017-12-27
Review2019-02-15

Application Sponsors

NDA 019219ALLERGAN

Marketing Status

Prescription002

Application Products

002SOLUTION/DROPS;OPHTHALMIC0.5%1BETAGANLEVOBUNOLOL HYDROCHLORIDE

FDA Submissions

TYPE 1; Type 1 - New Molecular EntityORIG1AP1985-12-19STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL2AP1987-09-15STANDARD
LABELING; LabelingSUPPL3AP1987-08-13
MANUF (CMC); Manufacturing (CMC)SUPPL4AP1988-10-21STANDARD
LABELING; LabelingSUPPL5AP1988-11-09
LABELING; LabelingSUPPL7AP1989-12-04
MANUF (CMC); Manufacturing (CMC)SUPPL9AP1989-12-06STANDARD
LABELING; LabelingSUPPL10AP1990-01-31
LABELING; LabelingSUPPL11AP1992-02-03
MANUF (CMC); Manufacturing (CMC)SUPPL12AP1994-01-13STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL13AP1995-08-03STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL14AP1995-06-12STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL15AP1998-02-12STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL16AP1998-05-01STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL17AP1998-05-19STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL18AP2000-10-02STANDARD
LABELING; LabelingSUPPL19AP2001-05-14STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL20AP2001-08-08STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL21AP2001-04-12STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL22AP2001-12-04STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL23AP2002-04-12STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL28AP2015-12-16STANDARD
LABELING; LabelingSUPPL29AP2017-12-22STANDARD

Submissions Property Types

SUPPL2Null0
SUPPL4Null0
SUPPL9Null0
SUPPL12Null0
SUPPL13Null0
SUPPL14Null0
SUPPL15Null0
SUPPL16Null0
SUPPL17Null0
SUPPL18Null0
SUPPL20Null0
SUPPL21Null0
SUPPL22Null0
SUPPL23Null0
SUPPL28Null0
SUPPL29Null15

TE Codes

002PrescriptionAT

CDER Filings

ALLERGAN
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 19219
            [companyName] => ALLERGAN
            [docInserts] => ["",""]
            [products] => [{"drugName":"BETAGAN","activeIngredients":"LEVOBUNOLOL HYDROCHLORIDE","strength":"0.5%","dosageForm":"SOLUTION\/DROPS;OPHTHALMIC","marketingStatus":"Prescription","te":"","rld":"Yes","rs":"Yes"}]
            [labels] => [{"actionDate":"12\/22\/2017","submission":"SUPPL-29","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2017\\\/019219s029lbl.pdf\"}]","notes":""},{"actionDate":"08\/08\/2001","submission":"SUPPL-20","supplementCategories":"Manufacturing (CMC)","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2001\\\/19219s20lbl.pdf\"}]","notes":"This supplement type does not usually require new labeling."}]
            [originalApprovals] => [{"actionDate":"BETAGAN","submission":"LEVOBUNOLOL HYDROCHLORIDE","actionType":"0.5%","submissionClassification":"SOLUTION\/DROPS;OPHTHALMIC","reviewPriority":"Prescription","inserts":"[]","notes":">Yes"}]
            [supplements] => 
            [actionDate] => 2017-12-22
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.